Terminology Service for NFDI4Health

B7 Transfected Melanoma Cell Vaccine

Go to external page http://purl.obolibrary.org/obo/NCIT_C2745


An allogenic whole tumor cell vaccine with potential antineoplastic activity. B7 transfected melanoma cell vaccine consists of melanoma cells that have been induced to express the human leukocyte antigen (HLA) B7. Vaccination with these altered cells may elicit an anti-tumor immune response via CD8+ cytotoxic T lymphocytes (CTL). (NCI04) [ ]

Term info

Label

B7 Transfected Melanoma Cell Vaccine

Synonyms
  • B7 Transfected Allogenic Melanoma Cell Vaccine
  • B7 Transfected Melanoma Cell Vaccine
Subsets

NCIT_C128784

Legacy Concept Name

B7_Transfected_Melanoma_Cell_Vaccine

NSC Code

666059

Preferred Name

B7 Transfected Melanoma Cell Vaccine

Semantic Type

Pharmacologic Substance, Immunologic Factor

UMLS CUI

C1516106

code

C2745